Highlights Demant A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 08:50:00 21/06/2024 pm IST			5-day change	1st Jan Change
305.4 ^DKK	-0.46%		-6.43%	+3.18%

29/05	UK’s Competition Regulator Closes Cochlear-Demant Deal	MT
21/05	Denmark's Demant Completes Sale of Cochlear Implants Business	MT

UK’s Competition Regulator Closes Cochlear-Demant Deal	29/05	MT
Denmark's Demant Completes Sale of Cochlear Implants Business	21/05	MT
Cochlear Limited acquired Oticon Medical A/s from Demant A/S.	21/05	CI
DEMANT : Q1 sales miss; organic growth guidance unchanged	06/05
Hearing Healthcare Company Demant Affirms FY24 Outlook	06/05	MT
Demant A/S Provides Earnings Guidance for the Year 2024	06/05	CI
Competition Regulator Clears Cochlear’s Acquisition of Oticon Medical’s Cochlear Implant Business	04/04	MT
Demant Seeks Acquisitions	12/03	CI
DEMANT : In-line Q4; markets cheer the promising takeaways for 2024	06/02
Global markets live: BP, Palantir, Infineon, Toyota, UBS...	06/02
Tranche Update on Demant A/S's Equity Buyback Plan announced on March 5, 2021.	06/02	CI
Demant A/S Reports Earnings Results for the Full Year Ended December 31, 2023	06/02	CI
Demant Forecasts Up to 8% Organic Revenue Growth in FY24	06/02	MT
Demant A/S Provides Earnings Guidance for the Year 2024	05/02	CI
Demant to Recommence Share Buybacks	21/11	MT
Demant Q3 revenue meets forecast, narrows outlook	07/11	RE
Demant A/S Provides Earnings Guidance for the Year 2023	07/11	CI
European Commission OKs Cochlear's Aquisition of Oticon Medical Unit	10/23/10	MT
Tranche Update on Demant A/S's Equity Buyback Plan announced on March 5, 2021.	15/23/15	CI
Demant A/S Updates Earnings Guidance for 2023	15/23/15	CI

No results for this search

DEMANT : Q1 sales miss; organic growth guidance unchanged

May 06, 2024 at 08:48 pm IST